Editor's Pick
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
Connect with us
Hi, what are you looking for?
Your Divident Investor
- Politics
Trump pick Emil Bove confirmed as federal judge after furious Democrat walkout, whistleblower complaints
Trump’s CDC pick confirmed—but her pro-vaccine stance may clash with RFK Jr.’s agenda
‘Critical’ closed-door congressional huddle focuses on growing antisemitism in US, Mamdani’s rise
Starmer says UK to recognize Palestinian state if Israel doesn’t agree to ceasefire, Hamas must ‘disarm’
Gaza Humanitarian Foundation: What to know about the US-backed aid group
- Stock
S&P 500 Breaking Out Again: What This Means for Your Portfolio
S&P 500 Breaking Out Again: What This Means for Your Portfolio
S&P 500 Breaking Out Again: What This Means for Your Portfolio
S&P 500 Breaking Out Again: What This Means for Your Portfolio
Chart Mania – 23 ATR Move in QQQ – Metals Lead 2025 – XLV Oversold – XLU Breakout – ITB Moment of Truth
- Investing
- Editor’s Pick
Union Pacific to buy Norfolk in $85 billion mega U.S. railroad deal
Things are getting better at Boeing under CEO Ortberg, but can he keep it going?
Elon Musk confirms Tesla has signed a $16.5 billion chip contract with Samsung Electronics
Palantir joins list of 20 most valuable U.S. companies, with stock more than doubling in 2025
FCC greenlights Paramount’s $8 billion merger with entertainment group Skydance
Stock
The S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the index has experienced since...
Politics
President Donald Trump addressed the ongoing hunger crisis in Gaza on Monday in Scotland, where he addressed the urgency of getting food into the...
Politics
The United Kingdom will recognize a Palestinian state if Israel does not agree to a ceasefire and move toward peace in Gaza by September,...
Politics
Lawmakers on the House Homeland Security Committee met with stakeholders and law enforcement to address the rise of antisemitic violence in the U.S., during...
Investing
From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major...
Investing
Editor's Pick
Editor's Pick
Editor's Pick
Politics
The Senate confirmed President Donald Trump’s pick to lead the Centers for Disease Control and Prevention after his first choice struggled to gain support....
Politics
The Senate confirmed President Donald Trump’s nominee Emil Bove as a federal judge Tuesday, handing a controversial leader at the Department of Justice a...
Investing
“Whatever is out of favor and hated at the moment, that’s probably what you need to buy,” he said. “Buy it when it’s boring...
Investing
Investor Insight With high-quality, drill-ready assets with world-class discovery potential, Piche Resources is a compelling business case for investors looking to leverage a bull...
Investing
When Canadian-Russian programmer Vitalik Buterin penned a white paper in 2013 outlining a new kind of blockchain platform, few could have predicted the seismic...
Editor's Pick
July 29 (Reuters) – Union Pacific said on Tuesday it would buy smaller rival Norfolk Southern in an $85-billion deal to create the country’s...
Stock
The S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the index has experienced since...
Editor's Pick
Colleen Hroncich Alexandra Batista was ready to quit teaching. Over the years, she had taught at various schools geared toward autistic children, but she...
Editor's Pick
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets....
Editor's Pick
Colin Grabow On occasion, and increasingly of late, one encounters the argument that libertarians and other free trade/free market types suffer from a blindspot concerning...
Editor's Pick
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated...
Investing
